{"name":"Presidio Pharmaceuticals, Inc.","slug":"presidio-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-31","type":"pipeline","source":"The Manila Times","summary":"NorthSea Therapeutics Bolsters Board, as Orziloben Moves into Late-stage Development - The Manila Times","headline":"NorthSea Therapeutics Bolsters Board, as Orziloben Moves into Late-stage Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNWW5hTTJSa1pVNWI2MFJPS1pnN1VPbXVYVy14ZVU5V0I0OFFUTFR0eXVqQktVMkhZU2ZzMXYtZ3Y5RW1NR09hRWJLVUlEV21XUW5ub0Y0dDBKV1ZERVg0MVZKamo1UmxvZjNYTDZUTnlmX1MzeDJVSmltU1dIOXJiQ2RsU1ptV1N6QVRZZExldmU3YnI3UXhfZmtfVDktZTZQRlZncEd3WjM2Tm5xTWJyMlA5UnR0cnlLXzlXdjV3ZWctNkxEZ0hXc0loSVQ3dw?oc=5","date":"2022-01-19","type":"pipeline","source":"Business Wire","summary":"Expansion Therapeutics Appoints Gary Bridger, Ph.D., to Its Board of Directors - Business Wire","headline":"Expansion Therapeutics Appoints Gary Bridger, Ph.D., to Its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOYmlwUjNpVUtIdmlSc1NYLUdsQVdRSWpVZER4TFVPM1NraGhhbzVnV2xWNUg5RzBuTWZ3RkZmcy11c3VLbHFBakpLYU54UDdNUVlObHlKNlZRbS1pdFd3MU9MTTlvV19EaV8wWGhDNWUxbEkzLVJQRnEzcWtaYnVPUW0yYjJjMWZoeFdYTkp3a2FiTzVHeURjcWdENFRHWlhxeVM5b1gzMVVVajVtbnVScGZPZmluV3lZUmQyMF9MVHU?oc=5","date":"2021-06-16","type":"pipeline","source":"European AIDS Treatment Group","summary":"First hepatitis C treatment developed through South-South cooperation registered in Malaysia - European AIDS Treatment Group","headline":"First hepatitis C treatment developed through South-South cooperation registered in Malaysia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNU1hsa3Y3VlU3ak9NU0Z3eE1PMEpnRU1DSTQ1M2lTM01VSzVXLXlRVzlSZTg1SGcwTl96WTJkdTNMZ0JkV0lOVHZjZ3dqXzJ1dGlZeFhIdTBFNGFZeThVQ1dUaEZKZzlUaGR0Z0ExaVR3N0JQQzRsRlRWV280OUNRY2hBbk5zdU1zX2F6aGdIYjBPZWVKcFJjem1qT1hPeW1DTlE?oc=5","date":"2017-04-21","type":"deal","source":"The Pharma Letter","summary":"Pharco and medicines charity reach deal on HCV candidate - The Pharma Letter","headline":"Pharco and medicines charity reach deal on HCV candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQSUhUUkdmTll3THdVUFR5ai1lT1RwN0VVeUQtb2RheWhUeWdNR2s0b3R5Z1FsMlJDY0VMOGg5cXZsNG1PZFZxaUdrVkVhYWg5eC1ybFBQZktWb0szOUJDNXNpNWxIdlMyM2I5ME9Sb1dMcV8tbjR4aC1Wd2RJM0JEY1BB?oc=5","date":"2017-01-16","type":"pipeline","source":"IPWatchdog.com","summary":"Thomas Anderton Joins Squire Patton Boggs in San Francisco - IPWatchdog.com","headline":"Thomas Anderton Joins Squire Patton Boggs in San Francisco","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}